0.65
+0.0799(+14.02%)
Currency In USD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1012
First IPO Date
June 16, 2022
| Name | Title | Pay | Year Born |
| Mr. Vilhelm Robert Wessman | Chief Executive Officer, Founder & Executive Chairman | 2.32M | 1969 |
| Ms. Jenny Sif Steingrimsdottir | Vice President of People & Culture | 0 | N/A |
| Mr. Johann G Johannsson | Executive Vice President of Capital Markets and M&A | 0 | N/A |
| Mr. Joseph E. McClellan | Chief Scientific & Technical Officer | 0 | 1974 |
| Mr. Benedikt Stefansson | Vice President of Investor Relations and Global Communications | 0 | N/A |
| Ms. Linda Jonsdottir | Chief Financial Officer | 0 | 1978 |
| Ms. Tanya Zharov | General Counsel | 0 | 1967 |
| Mr. Anthony M. Maffia III | Chief Regulatory Affairs Officer | 0 | N/A |
| Dr. Balaji Venkataramanan Prasad M.D. | Chief Strategy Officer | 0 | N/A |
| Mr. Uri Hillel | Chief Quality Officer | 0 | N/A |
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.